Here, we applied a monoclonal Dsg2 antibody (mAb) targeting the extracellular domain which we have shown to be inhibitory in a previous study [9] as well as AK23, an inhibitory monoclonal antibody from an active pemphigus mouse model targeting the Dsg3 adhesive interface [21], [22]. This evidence concerns the gene DSG2 and pemphigus.